These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3104344)

  • 1. The effects of different inactivating agents on the potency, toxicity and stability of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Jan; 15(1):87-98. PubMed ID: 3104344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of elevated temperatures on the opacity and toxicity of pertussis vaccines manufactured with different inactivating agents.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Vaccine; 1986 Sep; 4(3):185-90. PubMed ID: 3094265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Apr; 15(2):159-64. PubMed ID: 3110164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the optimal conditions for inactivation of Bordetella pertussis organisms with glutaraldehyde for preparation of a safe and potent pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1988 Dec; 6(6):491-6. PubMed ID: 2907704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaraldehyde inactivated pertussis vaccine: a safe vaccine in the innocuity test.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Vaccine; 1987 Jun; 5(2):102-4. PubMed ID: 2440196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative stabilities of glutaraldehyde & heat inactivated pertussis vaccine components of adsorbed DPT vaccine with different preservatives.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Indian J Med Res; 1992 Jan; 95():8-11. PubMed ID: 1577522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of formaldehyde on the toxicity and potency of pertussis vaccine.
    Gottshall RY; Nelson E; Angela F; Anderson G
    Health Lab Sci; 1975 Jan; 12(1):35-40. PubMed ID: 1053237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetone-treated pertussis vaccine--a potent and safer new pertussis vaccine.
    Saran G
    J Biol Stand; 1985 Oct; 13(4):315-20. PubMed ID: 4055808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine.
    Sawyer LA; McInnis J; Patel A; Horne AD; Albrecht P
    Vaccine; 1994 Jul; 12(9):851-6. PubMed ID: 7526574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutaraldehyde in whole-cell Bordetella pertussis vaccine.
    Arya SC; Ashraf SJ; Pathak VP
    Vaccine; 1989 Dec; 7(6):486. PubMed ID: 2514517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detoxification of Bordetella pertussis with glutaraldehyde.
    Iida T; Horiuchi Y
    J Biol Stand; 1987 Jan; 15(1):17-26. PubMed ID: 2881932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of glutaraldehyde inactivated pertussis vaccine.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Vaccine; 1990 Dec; 8(6):563-8. PubMed ID: 2128428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies on pertussis vaccine batches inactivated with glutaraldehyde, beta-propiolactone, formaldehyde or thiomersal.
    Andreescu V; Caffé I; Marion M; Ivan I; David C
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):299-308. PubMed ID: 122592
    [No Abstract]   [Full Text] [Related]  

  • 15. Quadruple vaccines containing pertussis and poliomyelitis vaccines.
    Anderson GR; Gottshall RY; Nelsom E; Angela F
    Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incompatibility of lyophilized inactivated polio vaccine with liquid pentavalent whole-cell-pertussis-containing vaccine.
    Kraan H; Ten Have R; van der Maas L; Kersten G; Amorij JP
    Vaccine; 2016 Aug; 34(38):4572-4578. PubMed ID: 27470209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the epinephrine-refractory hypoglycaemic activity of whole-cell pertussis vaccine in mice.
    Horiuchi Y; Iida T
    J Biol Stand; 1988 Oct; 16(4):239-48. PubMed ID: 3143732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of endotoxicity in bacterial vaccines.
    Wong KH; Miller CE; Feeley JC; Chan YK
    Appl Microbiol; 1973 Mar; 25(3):403-7. PubMed ID: 4633427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on Toxicity Reduction and Potency Induction in Whole-cell Pertussis Vaccine by Developing a New Optimal Inactivation Condition Processed on Bordetella pertussis.
    Mohammadpour Dounighi N; Razzaghi-Abyane M; Nofeli M; Zolfagharian H; Shahcheraghi F
    Jundishapur J Microbiol; 2016 Jul; 9(7):e34153. PubMed ID: 27679704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between mouse intracerebral potency & 50 per cent histamine sensitizing dose of pertussis vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Indian J Med Res; 1989 May; 89():144-9. PubMed ID: 2476391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.